Illumina upgraded to overweight at JPMorgan on clinical demand outlook
Go back to Illumina upgraded to overweight at JPMorgan on clinical demand outlook| Illumina, Inc. (NASDAQ: ILMN) | Delayed: 211.06 -7.16 (3.28%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $218.22 | 52 Week High | $196.47 | |||
| Open | $218.65 | 52 Week Low | $127.10 | |||
| Day High | $219.45 | P/E | 234.51 | |||
| Day Low | $210.15 | EPS | $0.90 | |||
| Volume | 1,819,805 | |||||
